![](/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMTgvMTEvMTMvaGFuZF9ob2xkaW5nX21hcmlqdWFuYV9idWRfaW5fdGVzdF90dWJlLWFkb2JlX3N0b2NrLWNyZWRpdC1mb3JhbmNlLXJlc2l6ZWQuanBn.V5VnAcNf7Ck.jpg?w=948&h=533&format=webp&mode=pad&anchor=middlecenter&scale=both&bgcolor=F0F1F2)
The state of Washington is about to hand out its very first cannabis research license. This new license allows companies to grow and process cannabis purely for research purposes.
Verda Bio, a Seattle-based pharmaceutical company, said they successfully received their research license and will soon be growing cannabis in their SoDo facility. The LCB confirmed that after a fee was processed the research license would be issued.
Jessica Tonani, Verda Bio’s CEO, said the company’s first project is a breeding program looking to create plants that produce minor cannabinoids, those rarer and less studied cannabis compounds. “The first year of the project is going to focus on breeding plants that produce chemicals outside of THC. We’re interested in creating plants that produce chemicals that we can study further,” Tonani said. “We don’t believe that the plants that we want to do research on exist yet.”
Top Image: © Forance | Adobe Stock
Latest from Cannabis Business Times
- Navigating Cultivation Room Design: Optimization vs. Maximization
- Verano Opens 18th Medical Cannabis Dispensary in Pennsylvania
- Hundreds Interested in Kentucky’s Medical Cannabis Licenses; Just 17 Apply So Far
- Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
- Curaleaf Opening 2 New York Medical Dispensaries, Launching Adult-Use Sales at 2 Other Stores
- Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July
- Planet 13 Launches Lifestyles Brand Company; Signs 1st Sponsored Athlete in UFC Title Contender Chito Vera
- LeafLink Acquires Leading Cannabis Banking Platform Dama Financial